MedTrace Logo

Developing Resiliency and Exercise Using AI-based Messaging

NCT07225283 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-05-18

No results posted yet for this study

Summary

This is a randomized, controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of the DREAM program, an 8-week message-based intervention to promote physical activity and well-being in adults with type 2 diabetes.

Conditions

  • Diabetes Mellitus Type 2

Interventions

BEHAVIORAL

DREAM

Participants will engage in twice weekly messaging sessions and will work towards a physical activity goal each week for a total of eight weeks.

Sponsors & Collaborators

Principal Investigators

  • Christopher M Celano, M.D. · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-03-31
Completion
2027-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07225283 on ClinicalTrials.gov